Hepatic profile in the patients receiving hepatitis treatment

The aim of the study was to evaluate the hepatic profile in the patients suffering from hepatitis c and receiving interferon treatment (after two months). individuals were divided into two groups including control (n=10) and patients (n=45). the hepatic profile (alt,ast,alp,total protein and bilirubin) was determined by commercially available kits. variations in the hepatic profile was statistically significant (p<0.05) between the control and patients groups. it can be concluded that continuous attention towards the patients regarding the hepatic profile must be delivered while they are receiving long therapy including interferon. moreover,hepatic protective treatment should also be considered.